Cantor A - Search Results

1

Improved survival in BRCA2 carriers with ovarian cancer.

Pal T, Permuth-Wey J, Kapoor R, Cantor A, Sutphen R. Pal T, et al. Among authors: cantor a. Fam Cancer. 2007;6(1):113-9. doi: 10.1007/s10689-006-9112-x. Fam Cancer. 2007. PMID: 17160431 Free PMC article.

2

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R. Pal T, et al. Among authors: cantor a. Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536. Cancer. 2005. PMID: 16284991 Free article.

3

Lysophospholipids are potential biomarkers of ovarian cancer.

Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys EC Jr, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K, Griffin D, Blanco RW, Cantor AB, Xiao YJ, Krischer JP. Sutphen R, et al. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1185-91. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247129

4

Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung.

Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Nordquist LT, et al. Among authors: cantor a. Chest. 2004 Aug;126(2):347-51. doi: 10.1378/chest.126.2.347. Chest. 2004. PMID: 15302716

5

Android obesity at diagnosis and breast carcinoma survival: Evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span,and survival from breast carcinoma.

Kumar NB, Cantor A, Allen K, Cox CE. Kumar NB, et al. Among authors: cantor a. Cancer. 2000 Jun 15;88(12):2751-7. doi: 10.1002/1097-0142(20000615)88:12<2751::aid-cncr13>3.0.co;2-1. Cancer. 2000. PMID: 10870057

6

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer.

Bepler G, Sharma S, Cantor A, Gautam A, Haura E, Simon G, Sharma A, Sommers E, Robinson L. Bepler G, et al. Among authors: cantor a. J Clin Oncol. 2004 May 15;22(10):1878-85. doi: 10.1200/JCO.2004.12.002. J Clin Oncol. 2004. PMID: 15143080

7

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G. Haura EB, et al. Among authors: cantor a. Clin Cancer Res. 2005 Dec 1;11(23):8288-94. doi: 10.1158/1078-0432.CCR-05-0827. Clin Cancer Res. 2005. PMID: 16322287

8

Molecular staging for survival prediction of colorectal cancer patients.

Eschrich S, Yang I, Bloom G, Kwong KY, Boulware D, Cantor A, Coppola D, Kruhøffer M, Aaltonen L, Orntoft TF, Quackenbush J, Yeatman TJ. Eschrich S, et al. Among authors: cantor a. J Clin Oncol. 2005 May 20;23(15):3526-35. doi: 10.1200/JCO.2005.00.695. J Clin Oncol. 2005. PMID: 15908663

9

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.

Simon GR, Sharma S, Cantor A, Smith P, Bepler G. Simon GR, et al. Among authors: cantor a. Chest. 2005 Mar;127(3):978-83. doi: 10.1378/chest.127.3.978. Chest. 2005. PMID: 15764785

10

Indirect economic effects of long-term breast cancer survival.

Chirikos TN, Russell-Jacobs A, Cantor AB. Chirikos TN, et al. Among authors: cantor ab. Cancer Pract. 2002 Sep-Oct;10(5):248-55. doi: 10.1046/j.1523-5394.2002.105004.x. Cancer Pract. 2002. PMID: 12236838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

553 results

Search Page

Filters